Wellington Shields & Co’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | – | Sell |
-1,000
| Closed | -$359K | – | 315 |
|
|
2026
Q2 | $359K | Hold |
1,000
| – | – | 0.08% | 193 |
|
|
2026
Q1 | $251K | Hold |
1,000
| – | – | 0.06% | 221 |
|
|
2025
Q4 | $275K | Hold |
1,000
| – | – | 0.07% | 206 |
|
|
2025
Q3 | $262K | Sell |
1,000
-500
| -33% | -$122K | 0.07% | 200 |
|
|
2025
Q2 | $328K | Hold |
1,500
| – | – | 0.09% | 167 |
|
|
2025
Q1 | $336K | Hold |
1,500
| – | – | 0.11% | 161 |
|
|
2024
Q4 | $491K | Hold |
1,500
| – | – | 0.15% | 129 |
|
|
2024
Q3 | $450K | Sell |
1,500
-500
| -25% | -$153K | 0.14% | 136 |
|
|
2024
Q2 | $659K | Hold |
2,000
| – | – | 0.21% | 103 |
|
|
2024
Q1 | $791K | Hold |
2,000
| – | – | 0.27% | 93 |
|
|
2023
Q4 | $704K | Hold |
2,000
| – | – | 0.26% | 90 |
|
|
2023
Q3 | $750K | Hold |
2,000
| – | – | 0.19% | 78 |
|
|
2023
Q2 | $765K | Hold |
2,000
| – | – | 0.18% | 83 |
|
|
2023
Q1 | $693K | Hold |
2,000
| – | – | 0.16% | 86 |
|
|
2022
Q4 | $471K | Hold |
2,000
| – | – | 0.11% | 122 |
|
|
2022
Q3 | $492K | Hold |
2,000
| – | – | 0.21% | 111 |
|
|
2022
Q2 | $605K | Hold |
2,000
| – | – | 0.15% | 92 |
|
|
2022
Q1 | $821K | Hold |
2,000
| – | – | 0.27% | 88 |
|
|
2021
Q4 | $938K | Hold |
2,000
| – | – | 0.19% | 82 |
|
|
2021
Q3 | $849K | Hold |
2,000
| – | – | 0.3% | 81 |
|
|
2021
Q2 | $718K | Hold |
2,000
| – | – | 0.24% | 88 |
|
|
2021
Q1 | $564K | Hold |
2,000
| – | – | 0.2% | 97 |
|
|
2020
Q4 | $567K | Hold |
2,000
| – | – | 0.2% | 88 |
|
|
2020
Q3 | $550K | Hold |
2,000
| – | – | 0.23% | 86 |
|
|
2020
Q2 | $454K | Hold |
2,000
| – | – | 0.2% | 101 |
|
|
2020
Q1 | $304K | Hold |
2,000
| – | – | 0.17% | 117 |
|
|
2019
Q4 | $301K | Buy |
+2,000
| New | +$291K | 0.13% | 134 |
|
|
2019
Q3 | – | Sell |
-2,000
| Closed | -$250K | – | 209 |
|
|
2019
Q2 | $250K | Hold |
2,000
| – | – | 0.12% | 149 |
|
|
2019
Q1 | $220K | Buy |
+2,000
| New | +$208K | 0.11% | 147 |
|
|
2018
Q4 | – | Sell |
-4,000
| Closed | -$494K | – | 168 |
|
|
2018
Q3 | $494K | Hold |
4,000
| – | – | 0.27% | 85 |
|
|
2018
Q2 | $397K | Hold |
4,000
| – | – | 0.21% | 95 |
|
|
2018
Q1 | $353K | Hold |
4,000
| – | – | 0.19% | 104 |
|
|
2017
Q4 | $395K | Hold |
4,000
| – | – | 0.21% | 100 |
|
|
2017
Q3 | $385K | Hold |
4,000
| – | – | 0.13% | 91 |
|
|
2017
Q2 | $378K | Hold |
4,000
| – | – | 0.13% | 88 |
|
|
2017
Q1 | $326K | Hold |
4,000
| – | – | 0.1% | 92 |
|
|
2016
Q4 | $339K | Buy |
+4,000
| New | +$315K | 0.18% | 86 |
|
Other funds holding WST
Wellington Shields & Co's WST Position: Q3 2026 in Review
Wellington Shields & Co sold out of West Pharmaceutical (WST) in Q3 2026, closing a stake of 1,000 shares — an estimated $359K sold.
Wellington Shields & Co first reported a position in WST in Q4 2016 and held it in 37 quarters. The position peaked at $938K in Q4 2021. 530 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Wellington Shields & Co reported no remaining West Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- Wellington Shields & Co sold 1,000 West Pharmaceutical shares in Q3 2026, an estimated $359K.
- Wellington Shields & Co first reported a position in West Pharmaceutical in Q4 2016 and held it in 37 quarters.
- Wellington Shields & Co's West Pharmaceutical position peaked at $938K in Q4 2021.
- 530 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Wellington Shields & Co's 13F filing for Q3 2026, filed 3 Nov 2026.